Search

Displaying 31 - 40 of 426

National Kidney Foundation and Labcorp Data Show Millions Aren’t Tested for Kidney Disease

Authors studied lab results for 28 million Americans with the highest risk and found most are not getting recommended tests to detect life-threatening disease

August 5, 2021, New York, NY — New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines despite their risk. The study, by authors from the National...

Brown Rice Linguine with Creamy Tofu Alfredo

Study Shows Race May Not Be Needed to Accurately Estimate Kidney Function

Dec. 7, 2020, New York, NY —A new study published today in the National Kidney Foundation’s American Journal of Kidney Diseases (AJKD) has found that it is possible to accurately assess patients for the stages of kidney disease without using race in the equation, which is currently routinely used as part of the diagnosis process in the United States.

Kidney disease affects an...

NKF and Debbie Allen Partner with Bayer to Launch New Initiative on Risk of CKD in People With T2D

Initiative Marks New Phase of the NKF “Are You the 33%?” National Kidney Disease Awareness Campaign

Whippany, N.J., – (BUSINESS WIRE) – February 4, 2021 – Bayer and the National Kidney Foundation (NKF) today announced that award-winning actress, Debbie Allen, has joined the “Are You the 33%?” national public awareness campaign to focus attention on the increased risk of developing chronic kidney disease (CKD), also referred to as...

National Kidney Foundation, Academy of Nutrition and Dietetics Release KDOQI Clinical Practice Guidelines on Nutrition

Aug. 20, 2020, New York, NY — The National Kidney Foundation (NKF) in collaboration with the Academy of Nutrition and Dietetics released today the 2020 Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline on Nutrition in Chronic Kidney Disease that will guide health...

Moonstone Nutrition and NKF partner to prevent kidney stones

September 29, 2020—Moonstone Nutrition and the National Kidney Foundation are partnering to raise awareness about the prevalence of kidney stones and the importance of overall kidney health. Moonstone Nutrition and NKF will develop educational materials to teach consumers and healthcare professionals about...

FLAVIS and the NKF Team-Up to Promote Kidney Health Through Diet

FLAVIS, the kidney friendly food brand, and the National Kidney Foundation partner to promote medical nutrition therapy to help maintain residual kidney function among chronic kidney disease patients New York, NY – April 8, 2019 – Dr. Schar USA’s (Lyndhurst, NJ) kidney friendly food brand, FLAVIS is teaming up with the National Kidney Foundation to...

National Kidney Foundation Honors Janssen Pharmaceutical Companies of Johnson & Johnson with 2020 Corporate Innovator Award

Company recognized for developing the first new treatment for diabetic kidney disease (DKD) to be approved by the FDA in nearly two decades. March 20, 2020, New York, NY —Janssen Pharmaceuticals Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson has been selected to receive the 2020 Corporate Innovator Award from the National Kidney Foundation (NKF) as part of the annual ...

National Kidney Foundation Awards Five Young Investigators Grants for Research

New York, NY–October 29, 2019 — Five young scientists have been awarded the National Kidney Foundation (NKF) Young Investigator Research Grants to advance knowledge about the treatment and prevention of kidney disease and kidney failure. This year’s grants, will go to Vishnu Potluri, University of Pennsylvania, Philadelphia; Laith Al-Rabadi, University of Utah Hospital, Salt Lake City; Cristian Riella, Beth Israel Deaconess...

NKF Sponsors Workshop to Examine New Therapy for Diabetic Kidney Disease

Dozens of experts, patients and policy makers expected to attend June 27, 2019, New York, NY – Nearly 80 nephrologists, cardiologists, diabetologists, patients and policy makers will gather in Chicago this week to share information about a human protein called sodium-glucose contransporter-2 (SGLT2), its role in diabetic kidney disease and how a new drug...